ACCEL DIAGNOSTICS, LLC

HOUSTON, TEXAS 770577100

$-2,825.37
Total Contract Value
2 awards
First Award
Aug 11, 2023
Last Award
Feb 14, 2024
Business Size
small
CAGE Code
5G0E4

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$-2,825.372

Contract Awards

1 awards found

75N92019C00002
Department of Health and Human Services
$-2,825.37
Aug 11, 2023

SBIR TOPIC 97 - PHASE II - MINIMALLY INVASIVE TEST FOR CHEMOTHERAPY-INDUCED CARDIOTOXICITY.

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023

Business Details

UEI
QUJ4EFCK59N4
CAGE Code
5G0E4
Address
5930 STAR LN SUITE C
HOUSTON, TX 770577100
Congressional District
TX-07

Parent Company

ACCEL DIAGNOSTICS, LLC

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov